Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model
The use of antibiotics is a vital means of treating infections caused by the bacteria <i>Bacillus (B.) anthracis</i>. Importantly, with the potential future use of multidrug-resistant strains of <i>B. anthracis</i> as bioweapons, new antibiotics are needed as alternative ther...
Main Authors: | William S. Lawrence, Jennifer E. Peel, Satheesh K. Sivasubramani, Wallace B. Baze, Elbert B. Whorton, David W. C. Beasley, Jason E. Comer, Dallas E. Hughes, Losee L. Ling, Johnny W. Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/9/9/773 |
Similar Items
-
Analysis of the Anthrax Morbidity Rate in the Russian Federation in 2011, and Prognosis for 2012
by: A. G. Ryazanova, et al.
Published: (2012-02-01) -
Cutaneous Anthrax—Still a Reality in India
by: Devinder Mohan Thappa
Published: (2019-07-01) -
Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001
by: Puneet K. Dewan, et al.
Published: (2002-10-01) -
Epidemiological Situation on Anthrax in the Russian Federation: Analysis of Morbidity in 2010, Prognosis for 2011
by: A. G. Ryazanova, et al.
Published: (2011-02-01) -
Prophylaxis Against Anthrax
by: Miroslav Špliňo, et al.
Published: (2002-01-01)